Skip to main content
Fig. 3 | BMC Gastroenterology

Fig. 3

From: Construction and validation of a predictive model for hepatocellular carcinoma based on serum markers

Fig. 3

Validation of the risk model in Wuxi cohort. A Performance of the risk model for predicting the onset of HCC. B Performance of the risk model for predicting the onset of HCC in patients with different AJCC TNM stages. C Decision curve analysis demonstrates the clinical net benefit of the risk score model for the onset of HCC. D–E Clinical impact curve of the risk model. F Predictive value of the risk model for the onset of HCC in patients with small tumor (< 2 cm)

Back to article page